Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewDevelopmentVascular biology Open Access | 10.1172/jci.insight.198032

Beta-arrestin 1/2 are essential for embryonic lymphatic vessel development

Yanna Tian,1 D. Stephen Serafin,1 Monserrat Avila-Zozaya,1 Alyssa M. Tauro,1 Natalie M. Torres-Valle,1 Bryan M. Kistner,1 Danielle M. Dy,1 Elizabeth S. Douglas,1 and Kathleen M. Caron1

1Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, United States of America

Find articles by Tian, Y. in: PubMed | Google Scholar

1Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, United States of America

Find articles by Serafin, D. in: PubMed | Google Scholar

1Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, United States of America

Find articles by Avila-Zozaya, M. in: PubMed | Google Scholar

1Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, United States of America

Find articles by Tauro, A. in: PubMed | Google Scholar

1Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, United States of America

Find articles by Torres-Valle, N. in: PubMed | Google Scholar

1Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, United States of America

Find articles by Kistner, B. in: PubMed | Google Scholar

1Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, United States of America

Find articles by Dy, D. in: PubMed | Google Scholar

1Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, United States of America

Find articles by Douglas, E. in: PubMed | Google Scholar |

1Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, United States of America

Find articles by Caron, K. in: PubMed | Google Scholar

Published March 26, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.198032.
Copyright © 2026, Tian et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published March 26, 2026 - Version history
View PDF
Abstract

β-arrestins are ubiquitously expressed cytosolic adaptor proteins that regulate G protein-coupled receptor-dependent and -independent pathways essential for numerous physiological functions. This study investigated the role of β-arrestin1 and -2 in embryonic lymphatic vessel development and survival by generating and characterizing mice with lymphatic, tamoxifen-inducible loss of the genes encoding β-arrestin-1 and -2 (Arrb1/2ΔiLEC). At embryonic day15.5 (E15.5), Arrb1/2ΔiLEC embryos exhibit profound hydrops fetalis and increased embryonic mortality compared to control Arrb1/2fl/fl embryos. Edematous Arrb1/2ΔiLEC embryos, which were more often represented by the female sex, showed growth restriction and decreased lymphatic endothelial cell (LEC) proliferation in the jugular lymphatic sac compared to controls. In vitro knockdown of β-arrestin1 in LECs increased proliferation and increased activation of AKT, while knockdown of β-arrestin2 decreased proliferation and decreased activation of both ERK and CREB. Arrb1/2ΔiLEC embryos also exhibited dilated dermal lymphatics with decreased continuous VE-Cadherin adherens junctions compared to controls. These results were recapitulated in vitro in β-arrestin1 and/or -2 knockdown human LECs, which showed a decrease in membrane VE-Cadherin and β-catenin levels, and prevention of adrenomedullin-induced linearization of VE-cadherin at endothelial cell–cell junctions. Collectively, these results demonstrate that loss of β-arrestin1/2 in lymphatics causes hydrops fetalis, mid-gestational growth arrest and embryonic demise associated with reduced LEC proliferation and disrupted VE-Cadherin adherens junctions.

Supplemental material

View

View Unedited blot and gel images

Version history
  • Version 1 (March 26, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts